Medicine
Neutral, non-partisan medicine coverage from around the world.
Insilico Medicine Launches Phase III Clinical Trial for Idiopathic Pulmonary Fibrosis Treatment
The study evaluates the efficacy and safety of the AI-discovered drug candidate Rentosertib in a large-scale, year-long trial.
University Medical Center Mainz Reports Success in First Clinical Trial of Activated Regulatory T Cells
New cell therapy approach shows promise in preventing graft-versus-host disease following stem cell transplants.
OYE Therapeutics Begins Phase 2 Clinical Trial for Anesthesia Recovery Drug
New intravenous caffeine formulation aims to accelerate patient emergence from general anesthesia after surgery.
Neuroptika Completes Patient Enrollment for Phase 2 Dry Eye Disease Trial
The clinical study evaluates a novel therapeutic designed to regenerate corneal nerves in patients with moderate-to-severe dry eye disease.
New Genetic Test Improves Risk Prediction for Aggressive Prostate Cancer
Researchers at Endeavor Health and GoPath Diagnostics have developed a tool to identify men at higher risk for severe disease progression.
FDA Approves Joenja for Children with Rare Immunodeficiency
The oral medication is the first treatment authorized in the United States for children aged 4 to 11 with APDS.
FDA Issues New Final Guidance to Strengthen Potency Standards for Cell and Gene Therapies
The updated regulatory framework emphasizes lifecycle-wide quality assurance for innovative treatments like CAR-T cell therapies.
Contrario Medical Receives FDA Clearance for New Sperm Separation Device
The Houston-based company's Cyperus device aims to improve outcomes for in vitro fertilization procedures.
HuiChuang Pharmaceutical Reports Positive Phase IIa Results for Fatty Liver Disease Drug
New oral medication HP515 shows significant reduction in liver fat content during 12-week clinical trial
United Kingdom and United States Establish New Regulatory Reliance Pathway for Medical Devices
New international cooperation aims to accelerate patient access to innovative surgical and diagnostic technologies by streamlining approval processes.
UK and US Establish Framework for Shared Medical Device Approvals
New regulatory cooperation aims to accelerate patient access to innovative surgical and diagnostic technologies.
UK Clinical Investigations for Medical Devices Reach Record Highs
The Medicines and Healthcare products Regulatory Agency reports a 17 percent increase in clinical trials for new health technologies.
New Immunotherapy Combination Sets Standard for Small Cell Lung Cancer Treatment
Clinical trial results indicate that combining immunotherapy with standard care significantly improves survival outcomes for patients with extensive-stage disease.
FDA Grants Approval for New Gene Therapy to Treat Recurrent Respiratory Papillomatosis
The new biological treatment aims to reduce the frequency of surgical excisions for adults suffering from the chronic condition.
FDA Approves Tavapadon as New Treatment Option for Parkinson's Disease
The regulatory approval marks a significant development for patients managing the motor symptoms of Parkinson's disease.
New HIV Dosing Regimen Approved for Newborns Following International Clinical Trial
Researchers establish safe and effective dolutegravir dosing for infants from birth to improve early treatment outcomes.
Pulsecare Medical Reports Positive Clinical Results for New Cardiac Ablation System
The third-generation nanosecond pulsed field ablation system shows promise for treating heart rhythm disorders with reduced anesthesia needs.
New Clinical Trial Launches for Rare PRKAG2 Syndrome Heart Condition
Atrium Therapeutics has begun the first interventional study to evaluate a potential new treatment for patients with this rare genetic heart disease.
X9 Receives FDA Breakthrough Device Designation for New Dialysis Cannulation System
The company also announced the completion of its second clinical study evaluating the investigational technology for hemodialysis patients.
HuiChuang Pharmaceutical Reports Positive Phase IIa Results for Metabolic Liver Disease Drug
New oral treatment HP515 shows significant reduction in liver fat content during 12-week clinical trial
Zzounds Music
We use Zzounds for all of our Musical Instrument and Recording needs. *Delivery anywhere *Financing available
Zzounds Music Homepage
LigaChem Biosciences Initiates Global Clinical Trial for New Gastric and Pancreatic Cancer Treatment
The experimental antibody-drug conjugate LCB02A aims to target CLDN18.2-positive tumors in a new phase 1/2 study.
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
New medication Hibsago offers a novel approach to managing chronic HBV infection in adults without cirrhosis.
FDA Approves New Targeted Therapy for Advanced Gastric Cancer
The drug Vyloy offers a new treatment option for patients with specific protein-positive stomach and esophageal tumors.
New Precision T-Cell Therapy Shows Promise in Clinical Trial for Treatment-Resistant Cancers
Early-stage research indicates that the drug invikafusp alfa may help patients with cancers that have not responded to traditional immunotherapies.
Page 1 of 6 · 139 articles